Apollomics
An innovative biopharmaceutical company committed to the discovery and development of oncology combination therapies.
Launch date
Employees
Market cap
€13.6m
Enterprise valuation
(€6m) (Public information from Sep 2024)
Share price
$0.127 APLM
Pleasanton California (HQ)
Authorizing premium user...